bioAffinity Technologies (BIAF) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BIAF bioAffinity Technologies

Watchlist

1.900
-0.060-3.06%

Close Jun 18 16:00 ET

1.860
-0.040-2.11%

Post 16:33 ET

22.15MMarket Cap-2043P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BioAffinity Technologies Sees Accelerating Growth Of Physician Practices Ordering CyPath Lung Tests
Sales of CyPath Lung tests, onboarding of pathology practices ahead of forecastsbioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW))), a biotechnology company focused on the need for noninvasive tests
BenzingaJun 12 08:11 ET
10-Q: Quarterly report
SEC announcementMay 15 10:56 ET · Announcements
Express News | BioAffinity Technologies Inc: Qtrly Shr Loss $0.21
ReutersMay 15 09:19 ET
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M
09:17 AM EDT, 05/15/2024 (MT Newswires) -- Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M
MT NewswiresMay 15 09:17 ET
Press Release: BioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath(R) Lung Sales and Increased Laboratory Volumes
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today reported financial results for the three months ended March 31, 2024.
Dow JonesMay 15 09:15 ET
Express News | BioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of Cypath® Lung Sales and Increased Laboratory Volumes
ReutersMay 15 09:15 ET

Comments

Stock Region

Mar 6 10:09

Medical Technology Company Reports Major Revenue Growth

bioAffinity Technologies: Accelerating the Future of Lung Cancer Detection with CyPath® Lung.
bioAffinity Technologies, a leading player in the field of early cancer detection, recently reported an acceleration in sales growth of its revolutionary product, CyPath® Lung. This surge signifies a growing demand for innovative, non-invasive methods for early lung cancer detection and highlights the potential of CyPath® Lung to revolutionize the i...